Sphingosine Kinase Mediates Resistance to the Synthetic RetinoidN-(4-Hydroxyphenyl)retinamide in Human Ovarian Cancer Cells

Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation

(2009) Satoshi Nemoto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells

(2009) S. E. Schnitzer et al.   MOLECULAR CANCER RESEARCH

Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug

(2009) J. Guillermet-Guibert et al.   MOLECULAR CANCER THERAPEUTICS

Sphingosine-1-Phosphate Receptor Subtypes Differentially Regulate Smooth Muscle Cell Phenotype

(2008) Brian R. Wamhoff et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction?

(2008) M VADAS   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease

(2008) Alfred H. Merrill et al.   JOURNAL OF LIPID RESEARCH

Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models

(2008) D. Pchejetski et al.   MOLECULAR CANCER THERAPEUTICS

N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing

(2008) H. Wang et al.   MOLECULAR CANCER THERAPEUTICS